DE1792716A1 - Pharmazeutische Praeparate,enthaltend Glucofuranoside - Google Patents
Pharmazeutische Praeparate,enthaltend GlucofuranosideInfo
- Publication number
- DE1792716A1 DE1792716A1 DE19591792716 DE1792716A DE1792716A1 DE 1792716 A1 DE1792716 A1 DE 1792716A1 DE 19591792716 DE19591792716 DE 19591792716 DE 1792716 A DE1792716 A DE 1792716A DE 1792716 A1 DE1792716 A1 DE 1792716A1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical preparations
- methyl
- glucofuranoside
- glucofuranosides
- preparations containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- CQRIWHZHWKQGQD-JWXFUTCRSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxy-2-methylhexanal Chemical compound O=C[C@@](O)(C)[C@@H](O)[C@H](O)[C@H](O)CO CQRIWHZHWKQGQD-JWXFUTCRSA-N 0.000 description 1
- SODQFLRLAOALCF-UHFFFAOYSA-N 1lambda3-bromacyclohexa-1,3,5-triene Chemical compound Br1=CC=CC=C1 SODQFLRLAOALCF-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- 208000000104 Arthus reaction Diseases 0.000 description 1
- 241000212384 Bifora Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 150000008153 D-glucofuranosides Chemical class 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010053614 Type III immune complex mediated reaction Diseases 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- -1 methyl - Chemical class 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6817059A CH391679A (de) | 1959-01-10 | 1959-01-10 | Verfahren zur Herstellung neuer Zuckerderivate |
| CH8031859A CH407077A (de) | 1959-11-06 | 1959-11-06 | Verfahren zur Herstellung neuer Zuckerderivate |
| CH8124759 | 1959-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1792716A1 true DE1792716A1 (de) | 1972-04-20 |
Family
ID=27178535
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19591443591 Pending DE1443591A1 (de) | 1959-01-10 | 1959-12-30 | Glucofuranoside und Verfahren zu ihrer Herstellung |
| DE19591792716 Pending DE1792716A1 (de) | 1959-01-10 | 1959-12-30 | Pharmazeutische Praeparate,enthaltend Glucofuranoside |
| DE19591792718 Pending DE1792718A1 (de) | 1959-01-10 | 1959-12-30 | Pharmazeutische Praeparate enthaltende Glucofuranoside |
| DE19591418126 Pending DE1418126A1 (de) | 1959-01-10 | 1959-12-30 | Glucofuranoside und Verfahren zu deren Herstellung |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19591443591 Pending DE1443591A1 (de) | 1959-01-10 | 1959-12-30 | Glucofuranoside und Verfahren zu ihrer Herstellung |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19591792718 Pending DE1792718A1 (de) | 1959-01-10 | 1959-12-30 | Pharmazeutische Praeparate enthaltende Glucofuranoside |
| DE19591418126 Pending DE1418126A1 (de) | 1959-01-10 | 1959-12-30 | Glucofuranoside und Verfahren zu deren Herstellung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3157634A (enExample) |
| AT (1) | AT241483B (enExample) |
| BE (1) | BE586369A (enExample) |
| DE (4) | DE1443591A1 (enExample) |
| DK (2) | DK126687B (enExample) |
| GB (2) | GB909279A (enExample) |
| MY (1) | MY6600016A (enExample) |
| SE (2) | SE301637B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2409654A1 (de) * | 1973-03-01 | 1974-09-12 | Strategic Medical Res Corp | Therapeutisches mittel |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH464957A (de) * | 1965-12-14 | 1968-11-15 | Sandoz Ag | Verfahren zur Herstellung eines neuen Glucosids |
| OA03606A (fr) * | 1967-01-16 | 1971-03-30 | Ciba Geigy | Procédé de préparation de nouveaux dérivés glucidiques. |
| US3455900A (en) * | 1967-05-19 | 1969-07-15 | Upjohn Co | Process for selectively preparing lincomycin 7-acylates |
| DE1793336C3 (de) * | 1967-09-11 | 1974-10-03 | Ciba-Geigy Ag, Basel (Schweiz) | D-Glucofuranoside, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
| CH510660A (de) * | 1967-09-11 | 1971-07-31 | Ciba Geigy Ag | Verfahren zur Herstellung neuer Glucofuranoside |
| US3538077A (en) * | 1967-09-26 | 1970-11-03 | Ciba Geigy Corp | D-glucofuranoside ether-esters |
| US3594473A (en) * | 1968-07-19 | 1971-07-20 | Ciba Geigy Corp | Anti-haemorrhoidally active preparations and the use of a d-glucofuranoside in such preparations |
| IL37955A0 (en) * | 1970-11-13 | 1971-12-29 | Ciba Geigy Ag | O-esters of monosaccharides,their manufacture and pharmaceutical compositions containing them |
| US3939146A (en) * | 1973-03-01 | 1976-02-17 | Strategic Medical Research Corporation | Novel ethereal monosubstitutions of monosaccharide derivatives |
| USRE30379E (en) * | 1973-03-01 | 1980-08-19 | Strategic Medical Research Corp. | Ethereal monosubstitutions of monosaccharide derivatives |
| US4056322A (en) * | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
| CH599242A5 (enExample) * | 1975-09-12 | 1978-05-31 | Ciba Geigy Ag | |
| US4950743A (en) * | 1987-07-29 | 1990-08-21 | Henkel Kommanditgesellschaft Auf Aktien | Process for preparation of alkylglycosides |
| DE19821949A1 (de) | 1998-05-15 | 1999-11-18 | Basf Ag | Verfahren zur Herstellung geträgerter Katalysatoren |
| JP5260093B2 (ja) * | 2008-03-10 | 2013-08-14 | クラレノリタケデンタル株式会社 | 重合性単量体、重合性組成物及び歯科用材料 |
| NL2007240C2 (en) * | 2011-08-09 | 2013-02-12 | Konink Co Peratie Cosun U A | Sugar-based plasticizers. |
| CN106046067A (zh) * | 2016-03-15 | 2016-10-26 | 山东康曼生物科技有限公司 | 1，2‑二‑o‑亚异丙基‑3，5，6‑三‑o‑苄基‑d‑呋喃葡萄糖的合成方法 |
| CN106589015A (zh) * | 2016-10-20 | 2017-04-26 | 利安隆（天津）实业有限公司 | 一种三苄糖苷的合成方法 |
| CN109776624B (zh) * | 2017-11-14 | 2022-02-08 | 鲁南制药集团股份有限公司 | 一种三苄糖苷的制备方法 |
-
1959
- 1959-12-21 DK DK462859AA patent/DK126687B/da unknown
- 1959-12-30 DE DE19591443591 patent/DE1443591A1/de active Pending
- 1959-12-30 US US862799A patent/US3157634A/en not_active Expired - Lifetime
- 1959-12-30 DE DE19591792716 patent/DE1792716A1/de active Pending
- 1959-12-30 DE DE19591792718 patent/DE1792718A1/de active Pending
- 1959-12-30 DE DE19591418126 patent/DE1418126A1/de active Pending
- 1959-12-31 GB GB1962/61A patent/GB909279A/en not_active Expired
- 1959-12-31 GB GB44483/59A patent/GB909278A/en not_active Expired
-
1960
- 1960-01-08 BE BE586369A patent/BE586369A/fr unknown
- 1960-01-08 AT AT12660A patent/AT241483B/de active
- 1960-01-09 SE SE178/60A patent/SE301637B/xx unknown
- 1960-11-03 DK DK434960AA patent/DK127056B/da unknown
-
1965
- 1965-03-30 SE SE04079/65A patent/SE332974B/xx unknown
-
1966
- 1966-12-31 MY MY196616A patent/MY6600016A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2409654A1 (de) * | 1973-03-01 | 1974-09-12 | Strategic Medical Res Corp | Therapeutisches mittel |
Also Published As
| Publication number | Publication date |
|---|---|
| GB909278A (en) | 1962-10-31 |
| US3157634A (en) | 1964-11-17 |
| DE1418126A1 (de) | 1969-12-04 |
| MY6600016A (en) | 1966-12-31 |
| DE1792718A1 (de) | 1972-03-30 |
| DK126687B (da) | 1973-08-13 |
| DK127056B (da) | 1973-09-17 |
| GB909279A (en) | 1962-10-31 |
| BE586369A (fr) | 1960-07-08 |
| AT241483B (de) | 1965-07-26 |
| SE332974B (enExample) | 1971-03-01 |
| DE1443591A1 (de) | 1969-08-28 |
| SE301637B (enExample) | 1968-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1792716A1 (de) | Pharmazeutische Praeparate,enthaltend Glucofuranoside | |
| DE69100275T2 (de) | Eine Trisaccharideinheit enthaltende Kohlenhydratderivate. | |
| DE2017265A1 (de) | l-(omega-substituierte-Alkyl)-2mehtylbenzimidazole und Verfahren zu deren Herstellung | |
| DE2652391C3 (de) | Daunosaminylanthracyclinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2051745A1 (de) | Von Nucleinsäuren stammende Arznei mittel und Verfahren zu ihrer Herstellung | |
| DE1445186C3 (de) | 3,3'-Di-2-imidazolin-2-yl-carbanilid | |
| CH637408A5 (de) | Verfahren zur herstellung von 6-fluor-17-alpha-pregnanderivaten. | |
| Broome et al. | A new drug for the treatment of fascioliasis in sheep and cattle | |
| DE2005959C3 (de) | Nitrochinohne | |
| DE2064296C2 (de) | Verfahren zur Herstellung eines injizierbaren Mittels gegen Viren der Mäuseleukämien | |
| CH493532A (de) | Verfahren zur Herstellung neuer, halogensubstituierter Tetrahydrochinazoline | |
| DE3308196A1 (de) | Verfahren zur herstellung von 6'-alkyl-spectinomycin sowie alkyl-spectinomycin-analogen | |
| DE69007439T2 (de) | Mittel gegen Tumore. | |
| DE3431236A1 (de) | Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation | |
| DE69000746T2 (de) | Praeparat zur behandlung von systemischem lupus erythomatosus. | |
| DE1252610B (de) | Verfahren zum Stabilisieren von Katalase | |
| DE1767666A1 (de) | Arzneimittel mit stabilisierender Wirkung auf den Cytometabolismus | |
| DE1518801C (de) | Neue Äther von 3 Mercapto ostratnenen und ein Verfahren zu ihrer Herstellung | |
| DE1617357A1 (de) | Injizierbarer Impfstoff gegen Influenza | |
| DE2135521A1 (de) | Neue Esterdenvate des Pyndylben zopyrans, Verfahren zu ihrer Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten | |
| DE1593838C3 (de) | Rutin-tri-(dihydroxypropyl)äther und Verfahren zu dessen Herstellung | |
| AT236411B (de) | Verfahren zur Herstellung von neuen Benzolsulfonyl-semicarbaziden | |
| AT236966B (de) | Verfahren zur Herstellung von neuen aliphatisch-heterocyclischen quaternären Ammoniumverbindungen | |
| AT236412B (de) | Verfahren zur Herstellung von neuen Benzolsulfonyl-semicarbaziden | |
| AT233735B (de) | Verfahren zur Herstellung von neuen Glucuronidverbindungen von basisch substituierten Derivaten des Pyrimido-[5,4-d]-pyrimidins |